Advertisement
Screener

NEXGEL, INC. (NXGL) Noncontrolling Interest, Increase from Business Combination

2.8 / 5 stars · 68/120 Roast Me

NEXGEL, INC. Noncontrolling Interest, Increase from Business Combination

NEXGEL, INC. (NXGL) reported Noncontrolling Interest, Increase from Business Combination of $38.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Shareholders' Equity

us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination · last filed 2026-03-31

  • NEXGEL, INC. noncontrolling interest, increase from business combination for the quarter ending 2024-06-30 was $37.00K.
  • NEXGEL, INC. noncontrolling interest, increase from business combination for the quarter ending 2023-03-31 was $500.00K.
  • NEXGEL, INC. noncontrolling interest, increase from business combination for fiscal 2024 was $38.00K, a 92.40% decline from fiscal 2023.
  • NEXGEL, INC. noncontrolling interest, increase from business combination for fiscal 2023 was $500.00K.
Period endNoncontrolling Interest, Increase from Business Combination 3 monthNoncontrolling Interest, Increase from Business Combination 12 month
2024-12-31$38.00K
10-K · filed 2026-03-31
2024-06-30$37.00K
10-Q · filed 2025-11-12
2023-12-31$500.00K
10-K · filed 2025-03-27
2023-03-31$500.00K
10-Q · filed 2024-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Tenon Medical, Inc. (TNON)United States$0.002B
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Profusa, Inc. (PFSA)United States$0.002B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B